Priority Healthcare Distribution Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Priority Healthcare Distribution Pharmaceutical Import Records from India — 4 Products, $4.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Priority Healthcare Distribution — Pharmaceutical Importer Profile (2026) | 4 Products, $4.3M Trade | TransData Nexus

Priority Healthcare Distribution

Pharmaceutical Importer · United States · Cardiovascular Focus · $4.3M Total Trade · DGFT Verified

Priority Healthcare Distribution is a pharmaceutical importer based in United States with a total trade value of $4.3M across 4 products in 2 therapeutic categories. Based on 99 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Priority Healthcare Distribution sources from 15 verified Indian suppliers, with Zydus Lifesciences Limited accounting for 26.1% of imports.

Priority Healthcare Distribution — Import Portfolio & Supplier Network

Priority Healthcare Distribution import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Priority Healthcare Distribution?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Zydus Lifesciences Limited	$7.9M	184	26.1%
Dr.reddy's Laboratories Limited	$5.1M	158	16.7%
Cipla Limited

What Formulations Does Priority Healthcare Distribution Import?

Formulation	Value	Ships
Pharmaceutical medicine for human use-	$1.6M	34
Pharmaceutical medicine for human use-	$689.5K	14
Metformin hydrochloride tabs USP 1000MG	$586.6K	12
Pharmaceutical medicine for human use-	$535.4K	11
Metformin hydrochloride tabs USP 500MG	$492.9K	12
Pharmaceutical medicine for human use-	$300.0K	6
Pharmaceutical medicine for human use- hydroxychloroquine sulfate tablets USP 200 MG - 1 x	$300.0K	6
Pharmaceutical medicine for human use- tamsulosin hcl cap USP 0.4 MG - 1 x	$300.0K	6
Pharmaceutical medicine for human use -ezetimibe TAB USP 10 MG - 1 x	$297.5K	7
Pharmaceutical medicine for human use- tamsulosin hcl cap USP 0.4 MG - 1 x	$250.0K	5
Pharmaceutical medicine for human use -tamsulosin hcl cap USP 0.4 MG - 1 x	$250.0K	5
300038464 omeprazoledrcapstusp20mg1000sq	$223.7K	9
Bupropion hcl er TAB USP 300MG 500s qualbupropion hydrochloride extended release tablets USP	$200.0K	4
Bupropion hcl er TAB USP 150MG 500s qualbupropion hydrochloride extended release tablets USP	$200.0K	4
Amlodipine besylate tablets USP 10 MG (inv.qty.3888 Pack 1x1000s=3888000 nos)	$182.5K	5

Priority Healthcare Distribution imports 587 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Metoprolol	Cardiovascular	$3.3M	76	0.4%	18
2	Carvedilol	Cardiovascular	$719.2K	17	0.7%	19
3	Chloroquine	Antimalarial & Antiparasitic	$150.0K	3	0.1%	15
4	Hydroxychloroquine	Antimalarial & Antiparasitic	$150.0K	3	0.1%	11

Priority Healthcare Distribution imports 4 pharmaceutical products across 2 categories into United States totaling $4.3M.

Priority Healthcare Distribution — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Priority Healthcare Distribution, Inc., operating under the trade name CuraScript Specialty Distribution, is a prominent pharmaceutical distributor based in Lake Mary, Florida. Established in 1992, the company specializes in the distribution of specialty pharmaceuticals and related medical supplies across the United States. In October 2005, Priority Healthcare was acquired by Express Scripts Holding Co., a leading pharmacy benefit management organization, enhancing its capabilities in specialty pharmaceutical distribution.

As a key player in the U.S. pharmaceutical supply chain, Priority Healthcare Distribution focuses on providing a wide range of specialty medications and medical supplies to healthcare providers, including hospitals, clinics, and physician offices. The company's operations are integral to ensuring the timely and efficient delivery of critical medications, thereby supporting the healthcare system's needs.

2Distribution Network

Priority Healthcare Distribution operates a comprehensive distribution network with multiple facilities strategically located across the United States. These facilities are equipped with advanced logistics capabilities to manage the storage and distribution of specialty pharmaceuticals and medical supplies. The company's geographic coverage spans the entire U.S., ensuring nationwide access to its products. Additionally, Priority Healthcare has engaged in federal contracts, indicating its involvement in supplying pharmaceuticals to various government agencies.

3Industry Role

In the U.S. pharmaceutical supply chain, Priority Healthcare Distribution functions primarily as a specialty pharmaceutical distributor. The company sources a diverse array of specialty medications and medical supplies from various manufacturers, including international suppliers, and delivers them to healthcare providers nationwide. This role is crucial in ensuring that healthcare providers have access to the necessary medications and supplies to deliver quality patient care.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Priority Healthcare Distribution

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Priority Healthcare Distribution's sourcing strategy exhibits a significant concentration on a select group of Indian pharmaceutical manufacturers. The company's total import value from India amounts to $4.3 million USD, encompassing 99 shipments and four distinct products across two therapeutic categories. The top five imported products include Metoprolol ($3.3 million), Carvedilol ($719,000), Chloroquine ($150,000), and Hydroxychloroquine ($150,000). This concentration indicates a strategic focus on specific therapeutic areas, particularly cardiovascular and antimalarial treatments.

The shipment data reveals a stable relationship with these Indian suppliers, as evidenced by the consistent import volumes over the years. This stability suggests a reliable supply chain and a strong partnership between Priority Healthcare Distribution and its Indian counterparts.

2Supply Chain Resilience

The resilience of Priority Healthcare Distribution's Indian supply chain is bolstered by its partnerships with multiple suppliers, including Zydus Lifesciences Limited, Dr. Reddy's Laboratories Limited, and Cipla Limited. This diversification mitigates the risks associated with single-source dependency. The company's import data indicates a diverse range of formulations, with 587 unique formulations imported, enhancing supply chain flexibility. While specific details on backup suppliers and shipping routes are not provided, the existing supplier diversity and formulation range suggest a robust and adaptable supply chain.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation, approval, and marketing of pharmaceutical products. The FDA enforces regulations that ensure the safety, efficacy, and quality of drugs entering the U.S. market. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which provides the legal framework for drug approval and regulation. The FDA's Center for Drug Evaluation and Research (CDER) is responsible for evaluating new drugs and monitoring the safety of existing drugs.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the U.S. are stringent. Foreign manufacturers must register their facilities with the FDA and list their products to obtain approval for importation. Good Manufacturing Practice (GMP) certification is mandatory, ensuring that drugs are produced consistently and controlled according to quality standards. The FDA recognizes GMP certifications from various international bodies, including the European Union (EU) and the World Health Organization (WHO), provided they meet FDA standards. Wholesale distributors like Priority Healthcare Distribution must also obtain appropriate licenses to operate legally within the U.S.

Priority Healthcare Distribution — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Priority Healthcare Distribution's focus on importing cardiovascular and antimalarial medications aligns with significant market demand in the United States. Cardiovascular diseases remain a leading cause of morbidity and mortality, driving the need for effective treatments. Similarly, antimalarial drugs are essential for treating and preventing malaria, particularly in regions with high incidence rates. The company's strategic emphasis on these therapeutic areas positions it to meet critical healthcare needs and capitalize on ongoing market demand.

2Sourcing Profile

Priority Healthcare Distribution's sourcing strategy centers on generic drugs, primarily from Indian manufacturers. The company's import data indicates a preference for specific formulations, such as Metoprolol and Carvedilol, highlighting a targeted approach to procurement. India's robust pharmaceutical manufacturing sector, characterized by cost-effective production and adherence to international quality standards, makes it a preferred sourcing destination for Priority Healthcare Distribution.

3Market Positioning

Based on its product mix, Priority Healthcare Distribution serves a diverse segment of the U.S. market, including retail pharmacies, hospitals, and government tenders. The company's focus on specialty pharmaceuticals enables it to cater to the needs of various healthcare providers, ensuring access to essential medications across different settings.

Seller's Guide — How to Become a Supplier to Priority Healthcare Distribution

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Priority Healthcare Distribution. The company's existing supplier base indicates a willingness to engage with multiple partners, and its focus on specific therapeutic areas presents avenues for introducing additional products. To capitalize on this opportunity, Indian exporters should ensure compliance with FDA regulations, maintain high-quality manufacturing standards, and demonstrate the ability to meet the specific needs of Priority Healthcare Distribution's product portfolio.

2Requirements & Qualifications

Indian exporters aiming to supply Priority Healthcare Distribution and the U.S. market must obtain FDA approval for their products, which involves facility registration, product listing, and adherence to GMP standards. Additionally, products must meet FDA labeling requirements, including English language labeling and serialization for traceability. Maintaining high-quality manufacturing practices and ensuring consistent product quality are essential qualifications for entering the U.S. pharmaceutical market.

3How to Approach

Frequently Asked Questions — Priority Healthcare Distribution

What products does Priority Healthcare Distribution import from India?

Priority Healthcare Distribution imports 4 pharmaceutical products across 2 categories. Top imports: Metoprolol ($3.3M), Carvedilol ($719.2K), Chloroquine ($150.0K), Hydroxychloroquine ($150.0K).

Who supplies pharmaceuticals to Priority Healthcare Distribution from India?

Priority Healthcare Distribution sources from 15 verified Indian suppliers. The primary supplier is Zydus Lifesciences Limited (26.1% of imports, $7.9M).

What is Priority Healthcare Distribution's total pharmaceutical import value?

Priority Healthcare Distribution's total pharmaceutical import value from India is $4.3M, based on 99 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Priority Healthcare Distribution focus on?

Priority Healthcare Distribution imports across 2 categories. The largest: Cardiovascular (93.1%), Antimalarial & Antiparasitic (6.9%).

Get Full Priority Healthcare Distribution Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.